Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-26-002905

Options or other derivatives

  • Chief Scientific Officer acquired 520,342 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Reich Kristian · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-07 Grant or award : show line 1 in the form Stock Option (Right to Buy) +520,342 520,342 D
Loading xslF345X05/ownership.xml…